Global Aptamers Market By Type (Peptide Aptamer, and Nucleic Acid Aptamer), By Application (Therapeutics, Diagnostics, Research and Development, and Other Applications), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Aptamers Market Overview:

The global market for aptamers was valued at USD 1,657 million in 2021. This market is expected to expand at a CAGR, of 22% between 2023-2032.

Aptamers have been gaining attention due to their many competitive advantages. These include recent advances in purification, production, drug delivery, and drug delivery to kill target cells. These advantages include a small molecular structure, low immunogenicity, and low manufacturing costs. They also have fewer side effects than antibodies. This could fuel market growth.

Global Aptamers Market Analysis

Type Analysis

The market’s largest segment was nucleic acids. This market is expected to see the most growth in the future. Numerous companies are studying the mechanism of action of nucleic acid aptamers for various disorders, such as age-related Macular Degeneration (AMD).

In 2021, the U.S. FDA approved a written agreement, under Special Protocol Assessment (SPA), for the design and execution of GATHER2 phase 3 to IVERIC BIO. A clinical trial of Zimura for patients with GA secondary AMD. This approval is expected to boost segment growth.

Because of its large user base for diagnostic and therapeutic purposes, the market for peptide-aptamers is expected to see significant growth. For example, the Engineering Center for Microtechnology and Diagnostics has developed a novel biosensor for multi-parametric expression testing in the preclinical diagnosis of cardiovascular disease.

Based on the molecular recognition and peptide aptamer markers system, next-generation biochips were developed for this purpose. Researchers used data from Protein 3D software and Data Bank to create peptide-aptamers. These products could help increase the usage of peptide Aptamers.

Application Analysis

In 2021, the research and development segment held a significant market share. The increasing demand for aptamers is coupled with increased research in this field driving the growth of the segment.

Collaborations, partnerships, and agreements are all keys to the R&D and development of new aptamers-based diagnostic and therapeutic products. Soma Logic Ltd. and Ixaka Ltd. established research collaboration in June 2021 with the goal of supporting the development and discovery of bispecific therapeutics using aptamers.

Due to its ability to rationally design antidotes, the therapeutics segment will experience significant market growth over the forecast period. These facts will all help the therapeutics sector to establish a strong market presence over the next period.

Key Market Segments

By Type

• Peptide Aptamer
• Nucleic Acid Aptamer

By Application

• Therapeutics
• Diagnostics
• Research and Development
• Other Applications

Market Dynamics

Because of the high number of genetic variants in COVID-19, there are not currently any highly effective treatments. Despite all efforts, biotechnological strategies are promising for COVID-19 treatment. The treatment of COVID-19 may be possible using aptamers based on nucleic acids and peptides.

To encourage the development of new treatments for COVID-19, governments have taken a variety of initiatives. Aptagen LLC received a US$ 320,000 contract from the Department of Community and Economic Development for the research and development of an innovative treatment for COVID-19 in September 2020.

The market is expected to grow with the introduction of diagnostic kits for disease diagnosis. Optimax, which is a COVID-19 diagnosis kit, was approved by Achiko AG in December 2021. AptameX is the second generation of a diagnostic kit that was developed using DNA aptamer-based technology. It is a cost-effective and emerging healthcare diagnostic tool.

Because of their small size, high selectivity, and specificity, aptamers are the best diagnostic and pathology products for diagnosing the disease at the cell level. Due to the rising prevalence of diseases such as cancer, CVD, and AMD, more patients may visit labs to diagnose these diseases. Aptamer-based diagnostic products are in high demand. Cancer Research U.K. estimates that 27.5 million people will be diagnosed by 2040 with cancer.

Regional Analysis

North America dominated aptamers in the 2021 market, accounting for 45.7% of the total revenue. The dominance of this region is due to the rising prevalence and strength of chronic diseases, as well as the growing interest in research laboratories in the area of aptamers.

The Asia Pacific is the region expected to experience the fastest growth during the forecast period. The approval of new aptamer-based products in the region is responsible for the region’s rapid growth. Achiko AG signed an agreement with Pengurus Wilayah Nahdlatul Ulama DKI in 2020. This is the largest Islamic association in Jakarta for the sales, marketing, and distribution of AptameX’s aptamer-based COVID-19 test kit AptameX.

Кеу Regions and Countries covered іn thе rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share & Key Players Analysis:

Major players are adopting strategies for approval for new products, modifications to the product, mergers, and acquisitions. ProAxsis Limited and Aptamer Group formed a partnership in August 2021 for the development of optimal ligands to be used in the diagnostic assays developed by ProAxsis. Optimer ligands can be next-generation nucleic acids-based affinity aptamers.

Key Market Players

• SomaLogic
• Aptamer Sciences Inc.
• Aptamer Group
• Noxxon Pharma
• Base Pair Biotechnologies
• Vivonics Inc.
• Aptagen, LLC
• TriLink Biotechnologies
• Other Key Players

For the Aptamers Market research study, the following years have been considered to estimate the market size: